4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-043987
Director sold 32,300 shares at an average $2.33 ($75,240)
- Director acquired 19,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Porter Derrell Director | 2026-06-15 | Option exercise | +6,460 | $1.07 | $6,912 | 54,760 | D |
| Porter Derrell Director | 2026-06-15 | Sale | −6,460 | $2.35 | $15,149 | 48,300 | D |
| Porter Derrell Director | 2026-06-16 | Sale | −12,800 | $2.33 | $29,773 | 35,500 | D |
| Porter Derrell Director | 2026-06-17 | Option exercise | +13,040 | $1.07 | $13,953 | 48,540 | D |
| Porter Derrell Director | 2026-06-17 | Sale | −13,040 | $2.33 | $30,318 | 35,500 | D |
| Derivatives | |||||||
| Porter Derrell Director | 2026-06-15 | Option exercise · Stock Option (right to buy) | −6,460 | 13,040 | D | ||
| Porter Derrell Director | 2026-06-17 | Option exercise · Stock Option (right to buy) | −13,040 | 0 | D | ||
| Open-market sales · 32,300 sh · avg $2.33 · $75,240 | |||||||
Loading xslF345X06/wk-form4_1781730613.xml…